Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,548 | 1,565 | 1,456 | 1,479 | 1,558 |
| Accounts receivable | -151 | -108 | -23 | -39 | 45 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 869 |
| Other Working Capital | 2,129 | -6,000 | 1,699 | 1,470 | 1,221 |
| Other Operating Activity | -66,982 | -47,067 | -44,301 | -21,623 | -21,459 |
| Operating Cash Flow | $-63,456 | $-51,610 | $-41,169 | $-18,713 | $-17,766 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -87 | -30 | -25 | 4 | -6 |
| Purchase Of Investment | 0 | -36,084 | -97,996 | -21,138 | -19,983 |
| Sale Of Investment | 7,884 | 36,093 | 90,018 | 31,135 | 20,010 |
| Other Investing Activity | -17 | -45 | 0 | -10 | -44 |
| Investing Cash Flow | $7,780 | $-66 | $-8,003 | $9,991 | $-23 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -127 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 223,118 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 20,737 | 4,014 | 175,152 | 42,615 | 839 |
| Financing Cash Flow | $243,728 | $4,014 | $175,152 | $42,615 | $839 |
| Beginning Cash Position | 117,967 | 165,629 | 39,649 | 5,756 | 22,706 |
| End Cash Position | 306,019 | 117,967 | 165,629 | 39,649 | 5,756 |
| Net Cash Flow | $188,052 | $-47,662 | $125,980 | $33,893 | $-16,950 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,456 | -51,610 | -41,169 | -18,713 | -17,766 |
| Capital Expenditure | -104 | -75 | -25 | -25 | -50 |
| Free Cash Flow | -63,560 | -51,685 | -41,194 | -18,738 | -17,816 |